Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1992
10/17/1992WO1992018513A1 New non-hygroscopic mono-ammonium salts
10/16/1992WO1992018148A1 An anti-hiv protein, tap 29, from trichosanthes, dna coding therefor and therapeutic uses thereof
10/16/1992WO1992018146A1 Novel biologically active peptide compositions and uses therefor
10/16/1992WO1992018143A1 Pharmaceutical compositions against gastric disorders
10/16/1992CA2108467A1 An anti-hiv protein, tap 29, from trichosanthes, dna coding therefor and therapeutic uses thereof
10/16/1992CA2083594A1 Biologically active peptide compositions and uses therefor
10/15/1992WO1992017606A1 Microassay system and neutrophil derived secretagogue
10/15/1992WO1992017602A1 Parathyroid hormone receptor and dna encoding same
10/15/1992WO1992017588A2 METHOD FOR PRODUCTION OF AN IgA BINDING PROTEIN DERIVED FROM GROUP B STREPTOCOCCI
10/15/1992WO1992017585A1 Odorant receptors ans uses thereof
10/15/1992WO1992017575A1 Novel leucine aminopeptidase
10/15/1992WO1992017567A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection of cell subsets
10/15/1992WO1992017506A1 MODULATION OF tPA ACTIVITY BY HEPARIN FRAGMENTS
10/15/1992WO1992017505A1 Monoclonal antibodies to stem cell factor receptors
10/15/1992WO1992017504A1 Macrophage cytotoxin compositions and methods of preparation
10/15/1992WO1992017500A1 Novel megakaryocyte amplifying factor and production thereof
10/15/1992WO1992017499A1 A unique hexapeptide derived from thrombospondin and its uses
10/15/1992WO1992017498A1 Product and method for improving keratinocyte adhesion to the dermis
10/15/1992WO1992017497A1 Human pf4a receptors and their use
10/15/1992WO1992017495A1 Antibiotic a 40926 ester derivatives
10/15/1992WO1992017490A1 Phosphorus containing compounds as inhibitors of retroviruses
10/15/1992WO1992017484A1 Single-stranded circular oligonucleotides
10/15/1992WO1992017456A1 Amino acid derivative and salt thereof
10/15/1992WO1992017445A2 S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
10/15/1992WO1992017436A1 Cross-linking agent
10/15/1992WO1992017207A1 MONOCLONAL ANTIBODIES WHICH BIND TO SECRETED AND MEMBRANE-BOUND IgE, BUT NOT TO IgE ON BASOPHILS
10/15/1992WO1992017206A1 Wound healing
10/15/1992WO1992017202A1 Medicaments containing human corticotropin releasing hormone (crh) alone or in combination with glucocorticoids
10/15/1992WO1992017201A1 Bradykinin antagonists
10/15/1992WO1992017200A2 Stable growth hormone metal ion formulations
10/15/1992WO1992017199A1 Compositions and methods for treating small cell and nonsmall cell lung cancers
10/15/1992WO1992017198A1 Dna and amino acid sequence specific for natural killer cells
10/15/1992WO1992017197A1 Novel peptide compositions and uses therefor
10/15/1992WO1992017194A1 Polyanionic polyamino acid inhibitors of mineral deposition and their synthesis
10/15/1992WO1992017193A1 Medicament containing an agent inhibiting in vivo pathological apoptosis and applications thereof
10/15/1992WO1992017191A1 Pharmaceutical dipeptide compositions and methods of use thereof
10/15/1992WO1992017184A2 Bioactive topical siloxane compositions having enhanced performance and safety
10/15/1992WO1992017176A1 Retroviral protease inhibiting compounds
10/15/1992WO1992017165A1 A single dose vaccination system
10/15/1992WO1992017151A2 Method of administering drugs through modification of epithelial tight junctions by tumor necrosis factor
10/15/1992WO1992017130A1 Local immunosuppression by polymer release of defined combinations of immunosuppressants
10/15/1992WO1992012717A3 A composition containing a tetracycline and use for inhibiting angiogenesis
10/15/1992WO1992011367A3 Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof
10/15/1992WO1992007939A3 Polypeptide with 46kd hmfg differentiation antigen binding specificity
10/15/1992WO1992007566A3 Antifungal activity of and prevention of drug induced nephrotoxicity by methylxanthine analogues
10/15/1992CA2407304A1 Human pf4a receptors and their use
10/15/1992CA2116362A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection of cell subsets
10/15/1992CA2107460A1 Pharmaceutical dipeptide compositions and methods of use thereof
10/15/1992CA2107217A1 Polyanionic polyamino acid inhibitors of mineral deposition and their synthesis
10/15/1992CA2106847A1 Odorant receptors and uses thereof
10/15/1992CA2106677A1 Bradykinin antagonists
10/15/1992CA2105864A1 Single-stranded, circular oligonucleotides
10/15/1992CA2103551A1 Method for production of an iga binding protein derived from group b streptococci
10/14/1992EP0508809A1 Proteinaceous lipid-containing particles
10/14/1992EP0508724A1 Radiopharmaceutical bacteriostats
10/14/1992EP0508672A2 Fish prolactin
10/14/1992EP0508665A2 Use of ACE inhibitors for lowering serum cholesterol
10/14/1992EP0508511A1 Compositions containing verapamil and trandolapril
10/14/1992EP0508472A2 Method of producing hybridomas
10/14/1992EP0508435A2 Pharmaceutical composition of stabilized [Leu 13]-motilin-Hse
10/14/1992EP0508417A2 Monoclonal antibody, polypeptides and production thereof
10/14/1992EP0508282A2 Anti-idiotypic monoclonal antibodies
10/14/1992EP0508221A1 Somatostatin receptor
10/14/1992EP0508220A1 Derivatives of amindinophenylalanine, procedure for their preparation, their utilisation and compositions comprising them
10/14/1992EP0508194A1 Stabilized factor VIII preparations
10/14/1992EP0507948A1 Monoclonal antibody, hybridomas, their production and use
10/14/1992EP0507908A1 Polypeptides having human dopaminergic receptor activity, nucleic acids coding for said polypeptides and uses thereof for screening active substances on said polypeptides
10/14/1992EP0507870A1 Polyhemoglobin stabilized by purine derivatives and glutathione.
10/14/1992EP0507868A1 Diagnostic probe for detecting human stomach cancer
10/14/1992EP0507836A1 Novel fibronectin receptor
10/14/1992EP0348429B1 Liver lactogenic factor
10/14/1992EP0303681B1 Immunosuppression in immunotoxin based human therapy
10/13/1992WO1992018153A1 Method of treating gastrointestinal ulcers with platelet derived growth factor
10/13/1992WO1992018107A1 Methods and formulations for use in inhibiting conception and in treating benign gynecological disorders
10/13/1992US5155218 Dna encoding human 5-ht1d receptors
10/13/1992US5155217 Ongogene encoding polypeptide having growth factor activity
10/13/1992US5155214 Basic fibroblast growth factor
10/13/1992US5155211 Megakaryocyte stimulatory factor
10/13/1992US5155210 Produce localized cytotoxic effects on target cells; antitumor and anticarcinogenic agents
10/13/1992US5155209 Anticarcinogenic, antitumor agents
10/13/1992US5155100 Treating cardiovascular disorders in mammals
10/13/1992US5155096 Method for potentiation of a therapeutic agent
10/13/1992US5155038 Administering to mammals
10/13/1992US5155027 Culturing cells having DNA construct encoding a polypeptide having a nonimmuno- and an immunologlobulin chain which dimerize to become biologically active
10/13/1992US5154931 Bound by solid carrier to application site; treatment of periodontal disease
10/13/1992US5154925 Treatment of tibial dyschondroplasia
10/13/1992US5154924 Method for delivering a neuropharmaceutical agent across the blood brain barrier to the brain of a host
10/13/1992US5154923 Polypeptides and derivatives thereof as well as their use in pharmaceutical and diagnostic compositions
10/13/1992US5154921 Removing cells from animal, contacting with polypeptide growth factor, GRO
10/13/1992CA1308864C Serine protease inhibitors
10/13/1992CA1308711C Derivatives of monophosphoryl lipid a and process for preparation
10/13/1992CA1308678C Lipases and lipase extracts, their preparation process and their therapeutic use
10/13/1992CA1308677C Monoclonal antibody capable of recognizing arteriosclerotic lesions and agents for detecting and treating arteriosclerosis
10/13/1992CA1308656C Hydrosols of pharmacalogically active agents and their pharmaceutical compositions comprising them
10/12/1992WO1992021700A1 Novel calcitonin, and production and use thereof
10/12/1992WO1992018117A1 Anti-thrombotic peptide and pseudopeptide derivatives
10/12/1992CA2107893A1 Anti-thrombotic peptide and pseudopeptide derivatives
10/11/1992WO1992018641A1 Interleukin-8 receptors and related molecules and methods
10/11/1992WO1992018621A1 Proteinaceous lipid-containing particles
10/11/1992WO1992018002A1 Nitrosation of homocysteine as a method for treating homocysteinemia
1 ... 2959 2960 2961 2962 2963 2964 2965 2966 2967 2968 2969 2970 2971 2972 2973 2974 2975 2976 2977 2978 2979 ... 3163